Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sabra Health Care REIT (SBRA)

Sabra Health Care REIT Q4 net income $0.19 per share vs $0.07; 2025 guidance set

Positive Impact 3 of 5 earnings Written later

Sabra Health Care REIT reported fourth-quarter 2024 net income of $46.7 million, or $0.19 per diluted share, compared with $17.2 million, or $0.07, a year earlier, and total revenues of $182.3 million versus $163.4 million. The company also introduced 2025 per-share earnings guidance, with Normalized AFFO expected at $1.48 to $1.51, above its 2024 Normalized AFFO of $1.44.

Key points

  • Q4 2024 total revenues $182.3 million, up from $163.4 million; net income $46.7 million, up from $17.2 million
  • Q4 2024 Normalized FFO $0.35 per diluted share (Q4 2023: $0.32); Normalized AFFO $0.36 (Q4 2023: $0.34)
  • 2025 guidance: Normalized FFO $1.43 to $1.46 and Normalized AFFO $1.48 to $1.51 per diluted share
  • Quarterly dividend of $0.30 per share declared February 3, 2025, payable February 28, 2025

The filing

CompanySabra Health Care REIT (SBRA)
Form8-K, current report
Filed with the SECFeb 19, 2025, 4:05 PM ET
Accession number0001492298-25-000007

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 19, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.